Showing results (1251-1260 of 1,893) with videos related to
Sort By:
Pageof 190
Immunotherapy|October 4, 2017
Nonconventional patterns of benefit of solid tumors treated with PD-(L)1 inhibitors: a systematic reviewOmar Abdel-RahmanImmunotherapy|October 3, 2017
Fostamatinib for persistent/chronic adult immune thrombocytopeniaAdrian Newland, Eun-Ju Lee, Vickie McDonald, et al.Immunotherapy|September 8, 2017
Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapySaeid Zanganeh, Ryan Spitler, Gregor Hutter, et al.Immunotherapy|December 15, 2015
Mepolizumab in the treatment of severe eosinophilic asthmaValentina Fainardi, Giovanna Pisi, Alfredo ChettaImmunotherapy|October 30, 2015
Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors: a meta-analysisOmar Abdel-Rahman, Hesham ElHalawani, Mona FouadImmunotherapy|November 25, 2015
PDL-1/PDL-2 blockade in mice dendritic cells by RNAi techniques to induce antitumor immunitySaeed Daneshmandi, Ali Akbar Pourfathollah, Mohammad Hossein Karimi, et al.Immunotherapy|May 21, 2016
Are there, or shall we discover, biomarkers to guide PD-1 inhibition?Paolo A Ascierto, Ramon Andrade de MelloImmunotherapy|May 11, 2016
Therapeutic anti-CD3 monoclonal antibodies: from bench to bedsideChantal Kuhn, Howard L WeinerImmunotherapy|May 4, 2016
Adoptive transfer of aminobisphonate-expanded Vγ9Vδ2+ T cells does not control HIV replication in a humanized mouse modelBhawna PooniaPageof 190